Broadcrest Asset Management LLC Sells 69,198 Shares of Transcat, Inc. $TRNS

Broadcrest Asset Management LLC trimmed its position in Transcat, Inc. (NASDAQ:TRNS) by 34.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 130,802 shares of the scientific and technical instruments company’s stock after selling 69,198 shares during the quarter. Transcat makes up approximately 21.7% of Broadcrest Asset Management LLC’s portfolio, making the stock its 3rd largest position. Broadcrest Asset Management LLC owned approximately 1.40% of Transcat worth $9,575,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the company. White Pine Capital LLC lifted its position in shares of Transcat by 1.7% in the 2nd quarter. White Pine Capital LLC now owns 10,175 shares of the scientific and technical instruments company’s stock valued at $875,000 after acquiring an additional 171 shares in the last quarter. Arkadios Wealth Advisors lifted its holdings in shares of Transcat by 3.3% in the second quarter. Arkadios Wealth Advisors now owns 5,814 shares of the scientific and technical instruments company’s stock valued at $500,000 after purchasing an additional 187 shares in the last quarter. Police & Firemen s Retirement System of New Jersey boosted its position in shares of Transcat by 14.8% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 2,238 shares of the scientific and technical instruments company’s stock worth $192,000 after buying an additional 288 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Transcat by 6.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company’s stock valued at $407,000 after buying an additional 325 shares in the last quarter. Finally, Morgan Dempsey Capital Management LLC grew its holdings in shares of Transcat by 41.7% during the second quarter. Morgan Dempsey Capital Management LLC now owns 1,352 shares of the scientific and technical instruments company’s stock valued at $116,000 after buying an additional 398 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on TRNS. Northland Securities set a $95.00 price objective on Transcat in a research note on Thursday, October 23rd. Weiss Ratings reiterated a “sell (d+)” rating on shares of Transcat in a report on Monday, December 29th. Finally, Zacks Research raised shares of Transcat from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 7th. Two investment analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $105.33.

Transcat Stock Down 0.5%

TRNS opened at $58.50 on Friday. Transcat, Inc. has a fifty-two week low of $50.23 and a fifty-two week high of $97.08. The business has a 50-day moving average of $58.78 and a 200-day moving average of $69.08. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.43 and a quick ratio of 2.06. The company has a market capitalization of $545.81 million, a PE ratio of 47.95 and a beta of 0.78.

Transcat (NASDAQ:TRNS) last announced its quarterly earnings results on Monday, November 3rd. The scientific and technical instruments company reported $0.44 EPS for the quarter, missing the consensus estimate of $0.46 by ($0.02). The firm had revenue of $82.27 million during the quarter, compared to the consensus estimate of $79.51 million. Transcat had a net margin of 3.75% and a return on equity of 6.81%. Equities research analysts forecast that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Transcat Company Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.